ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
You have a diagnosis of non-small cell lung cancer.
You have received no prior chemotherapy.
You have at least one measurable lesion.
You have an adequate performance status.
You are at least 18 years of age.
You may not be if
You have previously received chemotherapy for your lung cancer.
You have received radiation within the last 30 days.
You have active infection or other serious condition.
You have brain metastasis.
You have recently lost a significant amount of weight.
Clareo Health | ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
